vs
FirstCash Holdings, Inc.（FCFS）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是FirstCash Holdings, Inc.的1.2倍（$622.0M vs $501.3M），Royalty Pharma plc净利率更高（34.4% vs 20.8%，领先13.7%），FirstCash Holdings, Inc.同比增速更快（21.2% vs 4.8%），过去两年FirstCash Holdings, Inc.的营收复合增速更高（16.9% vs 4.6%）
FirstCash Holdings, Inc.是总部位于美国得克萨斯州沃斯堡的典当企业，在美国及拉丁美洲多地运营线下典当零售门店，为纳斯达克证券交易所公开上市企业，在美洲典当服务领域拥有成熟的业务布局与完善的运营网络。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
FCFS vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.2倍
$501.3M
营收增速更快
FCFS
高出16.4%
4.8%
净利率更高
RPRX
高出13.7%
20.8%
两年增速更快
FCFS
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $501.3M | $622.0M |
| 净利润 | $104.2M | $214.2M |
| 毛利率 | — | — |
| 营业利润率 | 28.5% | 62.4% |
| 净利率 | 20.8% | 34.4% |
| 营收同比 | 21.2% | 4.8% |
| 净利润同比 | 24.7% | 2.9% |
| 每股收益（稀释后） | $2.35 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FCFSRPRX
| Q4 25 | $501.3M | $622.0M | ||
| Q3 25 | $411.0M | $609.3M | ||
| Q2 25 | $385.1M | $578.7M | ||
| Q1 25 | $371.1M | $568.2M | ||
| Q4 24 | $413.7M | $593.6M | ||
| Q3 24 | $363.1M | $564.7M | ||
| Q2 24 | $363.5M | $537.3M | ||
| Q1 24 | $366.8M | $568.0M |
净利润FCFSRPRX
| Q4 25 | $104.2M | $214.2M | ||
| Q3 25 | $82.8M | $288.2M | ||
| Q2 25 | $59.8M | $30.2M | ||
| Q1 25 | $83.6M | $238.3M | ||
| Q4 24 | $83.5M | $208.2M | ||
| Q3 24 | $64.8M | $544.0M | ||
| Q2 24 | $49.1M | $102.0M | ||
| Q1 24 | $61.4M | $4.8M |
营业利润率FCFSRPRX
| Q4 25 | 28.5% | 62.4% | ||
| Q3 25 | 27.4% | 70.1% | ||
| Q2 25 | 21.1% | 36.3% | ||
| Q1 25 | 30.0% | 94.0% | ||
| Q4 24 | 26.5% | 60.9% | ||
| Q3 24 | 23.5% | — | ||
| Q2 24 | 18.2% | 50.2% | ||
| Q1 24 | 22.3% | -13.0% |
净利率FCFSRPRX
| Q4 25 | 20.8% | 34.4% | ||
| Q3 25 | 20.1% | 47.3% | ||
| Q2 25 | 15.5% | 5.2% | ||
| Q1 25 | 22.5% | 41.9% | ||
| Q4 24 | 20.2% | 35.1% | ||
| Q3 24 | 17.9% | 96.3% | ||
| Q2 24 | 13.5% | 19.0% | ||
| Q1 24 | 16.7% | 0.8% |
每股收益（稀释后）FCFSRPRX
| Q4 25 | $2.35 | $0.49 | ||
| Q3 25 | $1.86 | $0.67 | ||
| Q2 25 | $1.34 | $0.07 | ||
| Q1 25 | $1.87 | $0.55 | ||
| Q4 24 | $1.86 | $0.46 | ||
| Q3 24 | $1.44 | $1.21 | ||
| Q2 24 | $1.08 | $0.23 | ||
| Q1 24 | $1.35 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $125.2M | $618.7M |
| 总债务越低越好 | $2.2B | $9.0B |
| 股东权益账面价值 | $2.3B | $9.7B |
| 总资产 | $5.3B | $19.6B |
| 负债/权益比越低杠杆越低 | 0.98× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资FCFSRPRX
| Q4 25 | $125.2M | $618.7M | ||
| Q3 25 | $130.2M | $938.9M | ||
| Q2 25 | $101.5M | $631.9M | ||
| Q1 25 | $146.0M | $1.1B | ||
| Q4 24 | $175.1M | $929.0M | ||
| Q3 24 | $106.3M | $950.1M | ||
| Q2 24 | $113.7M | $1.8B | ||
| Q1 24 | $135.1M | $843.0M |
总债务FCFSRPRX
| Q4 25 | $2.2B | $9.0B | ||
| Q3 25 | $2.2B | $8.9B | ||
| Q2 25 | $1.7B | $8.0B | ||
| Q1 25 | $1.7B | $7.6B | ||
| Q4 24 | $1.7B | $7.6B | ||
| Q3 24 | $1.7B | $7.6B | ||
| Q2 24 | $1.7B | $7.6B | ||
| Q1 24 | $1.5B | $6.1B |
股东权益FCFSRPRX
| Q4 25 | $2.3B | $9.7B | ||
| Q3 25 | $2.2B | $9.6B | ||
| Q2 25 | $2.1B | $9.5B | ||
| Q1 25 | $2.1B | $9.8B | ||
| Q4 24 | $2.1B | $10.3B | ||
| Q3 24 | $2.0B | $10.3B | ||
| Q2 24 | $2.0B | $9.8B | ||
| Q1 24 | $2.0B | $9.9B |
总资产FCFSRPRX
| Q4 25 | $5.3B | $19.6B | ||
| Q3 25 | $5.2B | $19.3B | ||
| Q2 25 | $4.5B | $18.3B | ||
| Q1 25 | $4.4B | $17.6B | ||
| Q4 24 | $4.5B | $18.2B | ||
| Q3 24 | $4.4B | $18.0B | ||
| Q2 24 | $4.3B | $17.7B | ||
| Q1 24 | $4.2B | $16.1B |
负债/权益比FCFSRPRX
| Q4 25 | 0.98× | 0.92× | ||
| Q3 25 | 1.01× | 0.93× | ||
| Q2 25 | 0.79× | 0.84× | ||
| Q1 25 | 0.83× | 0.78× | ||
| Q4 24 | 0.85× | 0.74× | ||
| Q3 24 | 0.87× | 0.74× | ||
| Q2 24 | 0.85× | 0.78× | ||
| Q1 24 | 0.75× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $206.6M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.98× | 3.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FCFSRPRX
| Q4 25 | $206.6M | $827.1M | ||
| Q3 25 | $135.8M | $702.6M | ||
| Q2 25 | $116.9M | $364.0M | ||
| Q1 25 | $126.6M | $596.1M | ||
| Q4 24 | $198.1M | $742.5M | ||
| Q3 24 | $113.1M | $703.6M | ||
| Q2 24 | $106.2M | $658.2M | ||
| Q1 24 | $122.5M | $664.6M |
现金转化率FCFSRPRX
| Q4 25 | 1.98× | 3.86× | ||
| Q3 25 | 1.64× | 2.44× | ||
| Q2 25 | 1.95× | 12.06× | ||
| Q1 25 | 1.51× | 2.50× | ||
| Q4 24 | 2.37× | 3.57× | ||
| Q3 24 | 1.74× | 1.29× | ||
| Q2 24 | 2.16× | 6.45× | ||
| Q1 24 | 2.00× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FCFS
| US Pawn Segment | $292.2M | 58% |
| Retail POS Payment Solutions | $209.8M | 42% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
